Menu Close

Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2021
- The Future of Generics
Advertise

Diabetes

AstraZeneca/ Diabetes/ Diabetes/ News/ News/ R&D/ UK & Europe

AstraZeneca improves diabetes pen to maintain its market share

Piotr Wnuk AstraZeneca, Bydureon, Diabetes, GLP-1 0 Comment

The European Commission (EC) has approved AstraZeneca’s Bydureon BCise, a new weekly formulation of established GLP-1 diabetes drug

AstraZeneca improves diabetes pen to maintain its market share

https://pharmaphorum.com/news/astrazeneca-improves-diabetes-pen-to-maintain-its-market-share/

Diabetes/ Diabetes/ News/ News/ Patients

FDA warns of genital gangrene risk with diabetes drug class

Piotr Wnuk Diabetes, FDA warning, SGLT2 inhibitors 0 Comment

The US regulator released an official risk warning of a rare genital infection identified in 12 patients, including

FDA warns of genital gangrene risk with diabetes drug class

https://pharmaphorum.com/news/risk-sglt2-inhibitors-fda-warns/

Diabetes/ Diabetes/ News/ News/ News/ Novo Nordisk/ Patients/ R&D/ Top pharmaceutical companies/ Top stories

Novo’s diabetes pill beats injections in head-to-head trials

Piotr Wnuk Diabetes, diabetes care, GLP-1, Insuline, Januvia, Novo Nordisk, semaglutide, Sitagliptin, Type 2 diabetes, Victoza 0 Comment

Novo Nordisk is making the case for its diabetes pill, which it hopes will allow it to fight

Novo’s diabetes pill beats injections in head-to-head trials

https://pharmaphorum.com/news/novo-nordisks-success-with-oral-diabetes-drug/

Diabetes/ Diabetes/ Healthcare/ News/ News/ Patients

J&J seals $2.1bn deal on sale of major diabetes devices firm

Joy Persaud blood glucose monitor, Diabetes, Glucose, J&J, Johnson and Johnson, Platinum Equity 0 Comment

As part of its ongoing divestment program, a deal worth $2.1 billion has been struck between Johnson &

J&J seals $2.1bn deal on sale of major diabetes devices firm

https://pharmaphorum.com/news/jj-deal-glucose-monitoring-system/

Diabetes/ Digital/ Digital and Social Media/ News/ News

As competition hots up, J&J exits insulin pump market

Marco Ricci Animas, Diabetes, digital health, medical devices 0 Comment

A total of 297 employees to be laid off.

As competition hots up, J&J exits insulin pump market

https://pharmaphorum.com/news/animas-insulin-pump-north-america/

Diabetes/ Digital/ Digital and Social Media/ News/ News

Automatic artificial pancreas shows promise in trial

Marco Ricci artificial pancreas, Diabetes, digital health 0 Comment

Experimental device requires no user input at all.

Automatic artificial pancreas shows promise in trial

https://pharmaphorum.com/news/automatic-artificial-pancreas/

Diabetes/ Diabetes/ News/ US

ADA to re-evaluate tweet ban after backlash

Richard Staines 2017ADA, ADA 2017, ADA2017, Diabetes, legislation, R&D 0 Comment

ADA says photo ban is to protect intellectual property.

ADA to re-evaluate tweet ban after backlash

https://pharmaphorum.com/news/ada-re-evaluate-tweet-ban-backlash/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

Events

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Patient Engagement Event - a real world snapshot, beyond the talk

Post an event

See all

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise
pharmaphorum connect

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com

Trending

Diabetes

Login